Quashing of Prosecution Against Managing Director: High Court Rules on Vicarious Liability and Limitation in Substandard Drug Cases
In the judgment of Amit Kumar Bansal v. Union of India, the High Court of Himachal Pradesh quashed criminal complaints and summoning orders against the Managing Director of a pharmaceutical company. The Court ruled that criminal liability cannot be imposed on a director based solely on their designation and that the prosecution was barred by the statute of limitations.
Case Background: Substandard Quality Reports
The case involved samples of “Diclofenac Sodium” and “Montelukast Sodium” manufactured by M/s Theon Pharmaceuticals Limited. Drug Inspectors drew these samples in 2018, and subsequent laboratory reports from 2018 and 2019 declared them to be of “substandard quality”. Consequently, the Union of India filed criminal complaints under the Drugs and Cosmetics Act, 1940, impleading the company, its Wholetime Director, and the petitioner, who served as the Managing Director.
Key Legal Issue 1: Vicarious Liability (Section 34)
The petitioner challenged his inclusion in the case, arguing that he was not involved in the day-to-day manufacturing operations. The Court upheld this challenge based on several principles:
- Specific Averments Required: Under Section 34 of the Act, a person can only be held vicariously liable if they were “in charge of” and “responsible to” the company for the conduct of its business at the time of the offense.
- No Automatic Liability for Directors: The Court emphasized that there is “no magic” in the word “Director” or “Managing Director”. A complaint must specifically state how and in what manner a director was responsible for the alleged illegal act.
- Authorized Representatives: The company had formally appointed a Wholetime Director (Mr. Puran Chand Joshi) to perform day-to-day business functions, a fact known to the authorities. In the absence of specific allegations regarding the Managing Director’s role in manufacturing, the prosecution against him was deemed unsustainable.
Key Legal Issue 2: Bar of Limitation (Section 468 CrPC)
The Court found that the trial court’s decision to take cognizance was legally flawed due to the expiration of the limitation period:
- Punishment and Timeline: The offense under Section 27(d) carries a maximum punishment of two years. Under Section 468 of the CrPC, the limitation for taking cognizance of such an offense is three years.
- Commencement of Limitation: The three-year period began when the Drug Inspector received the analyst’s reports in August 2018 and March 2019.
- Delayed Cognizance: The trial court did not take cognizance until January 2022, which was well beyond the mandatory three-year window.
Final Ruling
The High Court concluded that continuing the trial against the petitioner would be a “sheer abuse of process of law” as the prosecution was “bound to fail”. The Court allowed the petition, quashed the complaints and summoning orders insofar as they related to the Managing Director, and discharged him from the cases.
STPL (Web) 2026 HP 160
Amit Kumar Bansal V. Union of India (D.O.J. 09-04-2026)
Loading Viewer...






